Biogen
North America, Massachusetts, United States, Cambridge
Description
Biogen is an American biotechnology company that provides therapeutics for neurological, autoimmune, and rare diseases.
Investor Profile
Biogen has made 29 investments, with 1 in the past 12 months and 28% as lead.
Stage Focus
- Series C (24%)
- Series Unknown (21%)
- Series B (17%)
- Series A (17%)
- Series D (7%)
- Corporate Round (3%)
- Grant (3%)
- Non Equity Assistance (3%)
- Post Ipo Equity (3%)
Country Focus
- United States (86%)
- Switzerland (3%)
- Germany (3%)
- South Korea (3%)
'%3e%3cg id='b'%3e%3cpath id='a' stroke='%23000' stroke-width='2' d='M-6-25H6m-12 3H6m-12 3H6'/%3e%3cuse xlink:href='%23a' y='44'/%3e%3c/g%3e%3cpath stroke='%23fff' d='M0 17v10'/%3e%3ccircle r='12' fill='%23cd2e3a'/%3e%3cpath fill='%230047a0' d='M0-12A6 6 0 0 0 0 0a6 6 0 0 1 0 12 12 12 0 0 1 0-24z'/%3e%3c/g%3e%3cg transform='rotate(-123.69)'%3e%3cuse xlink:href='%23b'/%3e%3cpath stroke='%23fff' d='M0-23.5v3M0 17v3.5m0 3v3'/%3e%3c/g%3e%3c/svg%3e)
- The Netherlands (3%)
Industry Focus
- Biotechnology
- Health Care
- Therapeutics
- Medical
- Life Science
- Pharmaceutical
- Biopharma
- Information Technology
- Health Diagnostics
- Manufacturing
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
